Alisporivir Inhibition of Hepatocyte Cyclophilins Reduces HBV Replication and Hepatitis B Surface Antigen Production
Open Access
- 1 February 2015
- journal article
- Published by Elsevier in Gastroenterology
- Vol. 148 (2) , 403-414.e7
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- Profile of alisporivir and its potential in the treatment of hepatitis CDrug Design, Development and Therapy, 2013
- The SARS-Coronavirus-Host Interactome: Identification of Cyclophilins as Target for Pan-Coronavirus InhibitorsPLOS Pathogens, 2011
- Inhibition of cyclophilins alters lipid trafficking and blocks hepatitis C virus secretionVirology Journal, 2011
- Hepatitis B Virus (HBV) Surface Antigen Interacts with and Promotes Cyclophilin A Secretion: Possible Link to Pathogenesis of HBV InfectionJournal of Virology, 2010
- Essential Role of Cyclophilin A for Hepatitis C Virus Replication and Virus Production and Possible Link to Polyprotein Cleavage KineticsPLOS Pathogens, 2009
- The Isomerase Active Site of Cyclophilin A Is Critical for Hepatitis C Virus ReplicationJournal of Biological Chemistry, 2009
- Debio 025, a Cyclophilin Binding Molecule, Is Highly Efficient in Clearing Hepatitis C Virus (HCV) Replicon-Containing Cells When Used Alone or in Combination with Specifically Targeted Antiviral Therapy for HCV (STAT-C) InhibitorsAntimicrobial Agents and Chemotherapy, 2009
- Hepatitis B Virus HBx Protein Localizes to Mitochondria in Primary Rat Hepatocytes and Modulates Mitochondrial Membrane PotentialJournal of Virology, 2008
- Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2008 updateHepatology International, 2008
- The cyclophilin inhibitor Debio-025 shows potent anti–hepatitis C effect in patients coinfected with hepatitis C and human immunodeficiency virusHepatology, 2008